Could a daily postbiotic help fight yeast infections?
NCT ID NCT06474247
First seen Jul 07, 2026 · Last updated Jul 08, 2026 · Updated 1 time
Summary
This trial investigates whether taking a postbiotic supplement daily for four weeks can help ease symptoms of vaginal yeast infections in women. Participants are sexually active women with a confirmed yeast infection. The study compares the postbiotic to a placebo to see if it improves symptoms and vaginal health.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- postbiotic
- What this could lead to
- If it works, this could offer a simple, non-drug option to help manage yeast infections alongside standard treatment.
- What could go wrong
- This is an early-to-mid stage trial with only 99 participants, so results may not apply to everyone. The postbiotic may not provide significant benefit over placebo.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 2/3
Runs two stages together: whether the treatment works, then large-scale confirmation.
- Participants
-
99 people
The number who actually took part.
- Started
-
Jun 2024
- Finished
-
Apr 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 81 years
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion criteria * Women who are sexually active * Confirmed with candidiasis as confirmed via clinical observations which include creamy whitish vaginal discharge and vulva-vaginal itchiness * Willing to commit throughout the experiment Exclusion criteria * Long term medication (6 months or more) for any illnesses * Pregnant * Menopaused * Uterus and/or cervix removed * Cervical intraepithelial neoplasia * Vaginal suppository treatments within 4-weeks prior to entering the study * Oral medication for vaginal illnesses or any vaginal therapy such as hormones and estrogen within 4-weeks prior to entering the study * Have used vaginal estrogen cream, ring or tablet within 4-weeks prior to entering the study * Have used vaginal moisturizers, lubricants or homeopathic preparations within 4-weeks prior to entering the study * Have used spermicide agent within 4-weeks prior to entering the study * Have pelvic or any gynecologic surgery 6-months prior to entering the study
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Vaginal candidiasis are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
AIMST University
Bedong, Kedah, Malaysia
-
Sumita Hospital
Lucknow, Aliganj, 226024, India
More trials for these conditions
Other studies related to the condition(s) this trial covers.